促性腺激素释放激素拮抗剂预防中重度卵巢过度刺激综合征的疗效分析(5)
[12]周妍，曾诚，尚鶄，等. 中、重度卵巢过度刺激综合征45例临床分析. 中国性科学， 2015， 24(4)：102-106.
[13]茹雪，张昌军. 中西医防治卵巢过度刺激综合征现代研究进展. 中国性科学， 2012， 21(12)：41-43.
[14]孔伟，闻姬，陈军. 两种促排卵方案对行IVF-ET的PCOS患者的临床研究. 中国性科学， 2012， 21(10)：3-8.
[15]Ragni G， Vegetti W， Riccaboni A， et al. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Human reproduction， 2005， 20(9)：2421-2425.
[16]Lainas GT， Kolibianakis EM， Sfontouris IA， et al. Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase： an observational cohort study. Reproductive Biology and Endocrinology ： RB&E， 2012(10)：69.
[17]Lainas GT， Kolibianakis EM， Sfontouris IA， et al. Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome. BJOG， 2014， 121(7)：848-855.
[18]Asimakopoulos B， Nikolettos N， Nehls B， et al. Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures. Fertility and Ssterility， 2006， 86(3)：636-641. (曾诚 尚鶄 徐阳 贺占举 单学敏 董朝彤 郐艳荣 王晟 薛晴)
[13]茹雪，张昌军. 中西医防治卵巢过度刺激综合征现代研究进展. 中国性科学， 2012， 21(12)：41-43.
[14]孔伟，闻姬，陈军. 两种促排卵方案对行IVF-ET的PCOS患者的临床研究. 中国性科学， 2012， 21(10)：3-8.
[15]Ragni G， Vegetti W， Riccaboni A， et al. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Human reproduction， 2005， 20(9)：2421-2425.
[16]Lainas GT， Kolibianakis EM， Sfontouris IA， et al. Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase： an observational cohort study. Reproductive Biology and Endocrinology ： RB&E， 2012(10)：69.
[17]Lainas GT， Kolibianakis EM， Sfontouris IA， et al. Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome. BJOG， 2014， 121(7)：848-855.
[18]Asimakopoulos B， Nikolettos N， Nehls B， et al. Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures. Fertility and Ssterility， 2006， 86(3)：636-641. (曾诚 尚鶄 徐阳 贺占举 单学敏 董朝彤 郐艳荣 王晟 薛晴)